Circulating Tumor DNA Guides Chemotherapy Use in Stage II Colon Cancer Posted Saturday June 4, 2022 Researchers from TGen, a part of City of Hope, contribute to study supporting value of ctDNA in assessing treatment options
TGen study offers path for late-stage cancer patients wanting to leverage their own health data to guide their care Posted Wednesday May 18, 2022